Is APYX or CARL more profitable?

Apyx Medical has a net margin of -14.78% compared to Carlsmed's net margin of -57.42%. Carlsmed's return on equity of -38.06% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -14.78% -76.60% -13.91% Carlsmed -57.42% -38.06% -28.96%

Apyx Medical (APYX) Competitors

$2.59 +0.23 (+9.75%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$2.70 +0.11 (+4.21%)

As of 10/9/2026 07:30 PM Eastern

Compare

APYX vs. SENS, OFIX, CARL, SI, and RCEL

Should you buy Apyx Medical stock or one of its competitors? Apyx Medical's main competitors and comparable companies include Senseonics Holdings, Inc. Common Stock (SENS), Orthofix Medical (OFIX), Carlsmed (CARL), Shoulder Innovations (SI), and Avita Medical (RCEL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Apyx Medical compare to Senseonics Holdings, Inc. Common Stock?

Apyx Medical (NASDAQ:APYX) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk.

In the previous week, Senseonics Holdings, Inc. Common Stock had 2 more articles in the media than Apyx Medical. MarketBeat recorded 3 mentions for Senseonics Holdings, Inc. Common Stock and 1 mentions for Apyx Medical. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 0.80 beat Apyx Medical's score of 0.00 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company	Overall Sentiment
Apyx Medical	Neutral
Senseonics Holdings, Inc. Common Stock	Positive

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Apyx Medical presently has a consensus target price of $6.50, indicating a potential upside of 150.97%. Senseonics Holdings, Inc. Common Stock has a consensus target price of $13.00, indicating a potential upside of 44.77%. Given Apyx Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Apyx Medical is more favorable than Senseonics Holdings, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75
Senseonics Holdings, Inc. Common Stock	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Apyx Medical has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.02, suggesting that its share price is 2% more volatile than the broader market.

Apyx Medical has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Apyx Medical is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.06	-$11.21M	-$0.20	N/A
Senseonics Holdings, Inc. Common Stock	$35.26M	10.65	-$69.11M	-$2.23	N/A

Apyx Medical has a net margin of -14.78% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Apyx Medical's return on equity of -76.60% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%

Summary

Apyx Medical beats Senseonics Holdings, Inc. Common Stock on 13 of the 17 factors compared between the two stocks.

How does Apyx Medical compare to Orthofix Medical?

Orthofix Medical (NASDAQ:OFIX) and Apyx Medical (NASDAQ:APYX) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Orthofix Medical presently has a consensus price target of $14.75, suggesting a potential upside of 60.85%. Apyx Medical has a consensus price target of $6.50, suggesting a potential upside of 150.97%. Given Apyx Medical's stronger consensus rating and higher probable upside, analysts clearly believe Apyx Medical is more favorable than Orthofix Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75

Orthofix Medical has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, Apyx Medical has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market.

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 55.3% of Apyx Medical shares are owned by institutional investors. 2.7% of Orthofix Medical shares are owned by insiders. Comparatively, 15.9% of Apyx Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Orthofix Medical had 2 more articles in the media than Apyx Medical. MarketBeat recorded 3 mentions for Orthofix Medical and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.00 beat Orthofix Medical's score of -0.18 indicating that Apyx Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Orthofix Medical	Neutral
Apyx Medical	Neutral

Orthofix Medical has a net margin of -7.41% compared to Apyx Medical's net margin of -14.78%. Orthofix Medical's return on equity of -14.05% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-7.41%	-14.05%	-7.17%
Apyx Medical	-14.78%	-76.60%	-13.91%

Apyx Medical has lower revenue, but higher earnings than Orthofix Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$822.31M	0.45	-$92.19M	-$1.54	N/A
Apyx Medical	$52.84M	2.06	-$11.21M	-$0.20	N/A

Summary

Apyx Medical beats Orthofix Medical on 10 of the 17 factors compared between the two stocks.

How does Apyx Medical compare to Carlsmed?

Apyx Medical (NASDAQ:APYX) and Carlsmed (NASDAQ:CARL) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, media sentiment, dividends, valuation and earnings.

Apyx Medical currently has a consensus target price of $6.50, suggesting a potential upside of 150.97%. Carlsmed has a consensus target price of $19.25, suggesting a potential upside of 33.50%. Given Apyx Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Apyx Medical is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Apyx Medical has a net margin of -14.78% compared to Carlsmed's net margin of -57.42%. Carlsmed's return on equity of -38.06% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Carlsmed	-57.42%	-38.06%	-28.96%

Apyx Medical has higher earnings, but lower revenue than Carlsmed. Apyx Medical is trading at a lower price-to-earnings ratio than Carlsmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.06	-$11.21M	-$0.20	N/A
Carlsmed	$63.30M	6.22	-$29.63M	-$1.43	N/A

Apyx Medical has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, Carlsmed has a beta of 2.09, meaning that its share price is 109% more volatile than the broader market.

In the previous week, Carlsmed had 4 more articles in the media than Apyx Medical. MarketBeat recorded 5 mentions for Carlsmed and 1 mentions for Apyx Medical. Carlsmed's average media sentiment score of 0.51 beat Apyx Medical's score of 0.00 indicating that Carlsmed is being referred to more favorably in the news media.

Company	Overall Sentiment
Apyx Medical	Neutral
Carlsmed	Positive

55.3% of Apyx Medical shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 12.9% of Carlsmed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Apyx Medical beats Carlsmed on 10 of the 17 factors compared between the two stocks.

How does Apyx Medical compare to Shoulder Innovations?

Apyx Medical (NASDAQ:APYX) and Shoulder Innovations (NYSE:SI) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

Apyx Medical has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market. Comparatively, Shoulder Innovations has a beta of -1.58, indicating that its share price is 258% less volatile than the broader market.

55.3% of Apyx Medical shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by insiders. Comparatively, 29.0% of Shoulder Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Apyx Medical has a net margin of -14.78% compared to Shoulder Innovations' net margin of -58.33%. Shoulder Innovations' return on equity of -23.61% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Shoulder Innovations	-58.33%	-23.61%	-19.53%

Apyx Medical has higher revenue and earnings than Shoulder Innovations. Apyx Medical is trading at a lower price-to-earnings ratio than Shoulder Innovations, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.06	-$11.21M	-$0.20	N/A
Shoulder Innovations	$47.32M	7.99	-$40.36M	-$1.92	N/A

In the previous week, Shoulder Innovations had 2 more articles in the media than Apyx Medical. MarketBeat recorded 3 mentions for Shoulder Innovations and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 0.00 equaled Shoulder Innovations'average media sentiment score.

Company	Overall Sentiment
Apyx Medical	Neutral
Shoulder Innovations	Neutral

Apyx Medical currently has a consensus target price of $6.50, indicating a potential upside of 150.97%. Shoulder Innovations has a consensus target price of $25.50, indicating a potential upside of 40.46%. Given Apyx Medical's stronger consensus rating and higher possible upside, analysts plainly believe Apyx Medical is more favorable than Shoulder Innovations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75
Shoulder Innovations	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Apyx Medical beats Shoulder Innovations on 10 of the 15 factors compared between the two stocks.

How does Apyx Medical compare to Avita Medical?

Apyx Medical (NASDAQ:APYX) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 15.9% of Apyx Medical shares are held by company insiders. Comparatively, 2.2% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Apyx Medical has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.99, suggesting that its share price is 99% more volatile than the broader market.

Apyx Medical currently has a consensus price target of $6.50, suggesting a potential upside of 150.97%. Avita Medical has a consensus price target of $11.40, suggesting a potential downside of 13.70%. Given Apyx Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Apyx Medical is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

In the previous week, Avita Medical had 3 more articles in the media than Apyx Medical. MarketBeat recorded 4 mentions for Avita Medical and 1 mentions for Apyx Medical. Avita Medical's average media sentiment score of 0.67 beat Apyx Medical's score of 0.00 indicating that Avita Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Apyx Medical	Neutral
Avita Medical	Positive

Apyx Medical has a net margin of -14.78% compared to Avita Medical's net margin of -56.96%. Avita Medical's return on equity of 0.00% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Avita Medical	-56.96%	N/A	-78.53%

Apyx Medical has higher earnings, but lower revenue than Avita Medical. Apyx Medical is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.06	-$11.21M	-$0.20	N/A
Avita Medical	$71.61M	5.68	-$48.59M	-$1.44	N/A

Summary

Apyx Medical beats Avita Medical on 9 of the 16 factors compared between the two stocks.

Get Apyx Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APYX vs. The Competition

Export

Metric	Apyx Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$99.41M	$5.44B	$7.16B	$13.21B
Dividend Yield	N/A	1.78%	2.53%	16.37%
P/E Ratio	-12.95	25.57	274.15	26.16
Price / Sales	2.06	83.25	635.98	112.53
Price / Cash	N/A	31.87	76.38	53.09
Price / Book	6.64	5.93	11.21	6.34
Net Income	-$11.21M	$146.18M	$3.50B	$381.90M
7 Day Performance	1.57%	-0.38%	-0.90%	-1.41%
1 Month Performance	-10.38%	-2.02%	-4.44%	-3.48%
1 Year Performance	-12.79%	5.08%	6.96%	1.16%

Apyx Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APYX Apyx Medical	2.8243 of 5 stars	$2.59 +9.7%	$6.50 +151.0%	-13.4%	$99.41M	$52.84M	N/A	205
SENS Senseonics Holdings, Inc. Common Stock	3.455 of 5 stars	$10.05 +2.1%	$17.20 +71.1%	N/A	$411.34M	$35.26M	N/A	130	Analyst Forecast
OFIX Orthofix Medical	2.5735 of 5 stars	$9.75 -0.9%	$14.75 +51.3%	-34.6%	$400.81M	$822.31M	N/A	1,605	News Coverage
CARL Carlsmed	2.6302 of 5 stars	$14.09 -0.6%	$19.25 +36.6%	+5.5%	$387.15M	$50.51M	N/A	127
SI Shoulder Innovations	2.2629 of 5 stars	$18.94 +5.5%	$25.50 +34.6%	+38.4%	$373.70M	$60.06M	N/A	75	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APYX) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apyx Medical (APYX) Competitors

APYX vs. SENS, OFIX, CARL, SI, and RCEL

How does Apyx Medical compare to Senseonics Holdings, Inc. Common Stock?

Summary

How does Apyx Medical compare to Orthofix Medical?

Summary

How does Apyx Medical compare to Carlsmed?

Summary

How does Apyx Medical compare to Shoulder Innovations?

Summary

How does Apyx Medical compare to Avita Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Apyx Medical (APYX) Competitors

APYX vs. SENS, OFIX, CARL, SI, and RCEL

How does Apyx Medical compare to Senseonics Holdings, Inc. Common Stock?

Does the media favor APYX or SENS?

Do insiders & institutionals believe in APYX or SENS?

Do analysts recommend APYX or SENS?

Which has more volatility and risk, APYX or SENS?

Which has preferable valuation and earnings, APYX or SENS?

Is APYX or SENS more profitable?

Summary

How does Apyx Medical compare to Orthofix Medical?

Do analysts recommend OFIX or APYX?

Which has more volatility & risk, OFIX or APYX?

Do institutionals and insiders hold more shares of OFIX or APYX?

Does the media refer more to OFIX or APYX?

Is OFIX or APYX more profitable?

Which has stronger earnings & valuation, OFIX or APYX?

Summary

How does Apyx Medical compare to Carlsmed?

Do analysts prefer APYX or CARL?

Is APYX or CARL more profitable?

Which has better valuation and earnings, APYX or CARL?

Which has more volatility & risk, APYX or CARL?

Does the media refer more to APYX or CARL?

Do institutionals & insiders have more ownership in APYX or CARL?

Summary

How does Apyx Medical compare to Shoulder Innovations?

Which has more risk & volatility, APYX or SI?

Do institutionals and insiders believe in APYX or SI?

Is APYX or SI more profitable?

Which has stronger earnings and valuation, APYX or SI?

Does the media refer more to APYX or SI?

Do analysts recommend APYX or SI?

Summary

How does Apyx Medical compare to Avita Medical?

Do insiders & institutionals hold more shares of APYX or RCEL?

Which has more volatility and risk, APYX or RCEL?

Do analysts prefer APYX or RCEL?

Does the media prefer APYX or RCEL?

Is APYX or RCEL more profitable?

Which has preferable valuation & earnings, APYX or RCEL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

APYX vs. The Competition

Apyx Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools